Figure 2.
The nomogram for predicting RFS of early-stage IBC patients with HR+. RFS, relapse-free survival; IBC, invasive breast cancer; HR, hormonal receptor; TOP2A, topoisomerase II alpha; HER2, human epidermal growth factor receptor 2.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.